Wall Street appears to like CVS (CVS) CEO David Joyner's conservative approach to the company's 2025 financial outlook, rewarding the stock with a nearly 15% bump by market close Wednesday.

CVS Health CEO David Joyner went on the defense of the pharmacy benefit management industry on the company's fourth-quarter earnings call Wednesday morning. PBMs have been under intense scrutiny ...

CVS (CVS) CEO David Joyner has an ambitious plan to revamp the company's retail healthcare business and create a more integrated system of health professionals, which would change the way ...

Wall Street appears to like CVS (CVS) CEO David Joyner's conservative approach to the company's 2025 financial outlook, rewarding the stock with a nearly 15% bump by market close Wednesday. Joyner ...

Wall Street appears to like CVS (CVS) CEO David Joyner's conservative approach to the company's 2025 financial outlook, rewarding the stock with a nearly 15% bump by market close Wednesday. Joyner ...

CVS Health CEO David Joyner defended controversial pharmacy middlemen, who are widely accused of inflating prescription medication prices, and instead accused manufacturers of "monopolistic ...

CVS (CVS) CEO David Joyner has an ambitious plan to revamp the company's retail healthcare business and create a more integrated system of health professionals, which would change the way pharmacists, ...